Istanbul Medeniyet University
medeniyet.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
186
Active
22
Phase 3
1
Total enrollment
37,032
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Standard COPD Pharmacological Therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-06-30
Top conditions
- Stroke8
- Anxiety6
- Procedural Pain5
- Pain5
- Exercise4
- Pain Management4
- Multiple Sclerosis4
- Healthy4
Frequently asked questions about Istanbul Medeniyet University
- How many clinical trials does Istanbul Medeniyet University have on ClinicalTrials.gov?
- Istanbul Medeniyet University is listed as the lead sponsor on 186 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istanbul Medeniyet University's trials are in Phase 3?
- 1 of Istanbul Medeniyet University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Istanbul Medeniyet University focus on?
- Istanbul Medeniyet University's most-studied conditions on ClinicalTrials.gov are Stroke, Anxiety, Procedural Pain, Pain, Exercise.
- When are Istanbul Medeniyet University's next clinical trial readouts?
- Istanbul Medeniyet University has 1 upcoming primary-completion readout tracked here; the soonest is “Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD”, expected around 2025-06-30.